Callie Care Raises $500K Pre-Seed for Phone-First AI Eldercare

When families think about caring for aging loved ones, the hardest question is often the simplest: "Are they okay?" Callie Care is betting that answering it does not require another app. It starts with something millions of older adults already know how to use: the telephone.

The Wilmington, Delaware-based AgeTech startup closed a $500K pre-seed funding round backed by angel investors, while also receiving additional non-dilutive support from InterSystems Ventures. Funding was announced in early July 2026, and the amount of the non-dilutive support was not disclosed. Co-founder and CEO Yury Palevich leads the company alongside co-founders Igor Gurovich and Michil Androsov.

The funding matters beyond the balance sheet because it reflects continued investor interest in healthcare AI built for practical adoption rather than technological theater. Instead of asking older adults to adapt to unfamiliar software, Callie Care designed its platform around a device many already trust and understand.

What Happened

Callie Care has developed a phone-first AI companion that proactively calls older adults, conducts wellness conversations, provides medication reminders, assists with everyday needs such as grocery coordination and transportation, and keeps families and caregivers informed through ongoing updates. The product sits at the intersection of AgeTech, healthcare AI, voice AI, and remote eldercare support, with a clear bias toward simple daily interaction instead of another dashboard.

The company announced a $500K pre-seed round backed by angel investors. Alongside that equity financing, InterSystems Ventures provided non-dilutive support intended to help accelerate infrastructure development and healthcare interoperability initiatives. The company did not identify a lead investor, and the amount of the InterSystems Ventures support remains undisclosed.

Rather than positioning AI as a replacement for human care, Callie Care frames it as another layer in the support network around older adults. That positioning matters because families, home care providers, senior living operators, and healthcare organizations need better visibility without stripping away the human element of care.

Why This Matters

Healthcare innovation often struggles with adoption because products are designed for technology enthusiasts instead of the people expected to use them. Callie Care approaches the problem from the opposite direction by making the telephone, not the smartphone, the primary interface. Familiarity becomes an accessibility feature rather than a design compromise.

That philosophy reflects a broader shift across AgeTech and digital health. The companies gaining attention are increasingly those that simplify interactions instead of adding more digital complexity. Technology succeeds when it disappears into everyday routines, and that is especially true for older adults who may not want another login, screen, or notification.

Callie Care also addresses a growing pressure point for family caregivers. Millions of families balance work, children, distance, and aging parents while trying to monitor wellbeing from across town or across the country. Daily AI-powered conversations can create another layer of visibility without replacing professional care, family involvement, or clinical judgment.

Market Context

The company's market opportunity extends beyond direct consumer adoption. Callie Care is building for families while also targeting home care agencies, senior living communities, health insurers, home health providers, and value-based care organizations. That multi-channel strategy reflects where healthcare technology is moving: useful tools increasingly have to serve both consumers and the institutional systems around them.

InterSystems Ventures' participation aligns with that strategy. Interoperability matters because eldercare and healthcare support often break down when information sits inside disconnected systems. If Callie Care can turn everyday voice interactions into trusted, usable signals for caregivers and care organizations, the company has a stronger enterprise story than a consumer companion app alone.

Early Traction

Early-stage funding tells one story. User behavior tells another. According to the company, more than 8,000 users have tried Callie Care since its MVP launched, 85% of engaged users requested continued regular calls, conversations average roughly 10 minutes, and the platform has accumulated more than 730 hours of dialogue with older adults.

Those metrics matter because voice products are difficult to fake. Users either keep answering the phone or they do not. Consistent engagement suggests the platform is creating conversations people find useful rather than interactions they tolerate once and ignore.

The company is also advancing technology that analyzes vocal biomarkers to help identify potential cognitive decline while continuing to develop interoperable healthcare infrastructure for enterprise deployments. These initiatives remain active areas of development rather than fully commercialized diagnostic capabilities.

What This Signals

The next generation of healthcare AI may not arrive through the flashiest demos or the most sophisticated interfaces. It may come through products that quietly fit into everyday life and reduce friction for populations often overlooked by mainstream consumer technology. Callie Care's phone-first approach is a reminder that the best interface is sometimes the one users already understand.

For founders, there is a sharper lesson embedded in this round. The strongest early-stage companies often earn investor confidence because they remove unnecessary complexity for the people who need the product most. Callie Care did not ask older adults to adapt to technology. It asked technology to adapt to older adults, and that may prove to be one of the more durable ideas in healthcare AI.